SCHEMBL3308965

SCHEMBL3308965

c1ccc(C2C3CC4CC(C3)CC2C4)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 8/20 0.41
MAOA P21397 7/20 0.41
KDM1A O60341 5/20 0.41
CYP2C19 P33261 4/20 0.41
CYP2B6 P20813 3/20 0.41
CYP1A2 P05177 2/20 0.41
CYP2D6 P10635 2/20 0.41
CYP2C9 P11712 2/20 0.41
LMNA P02545 2/20 0.41
TAAR1 Q96RJ0 2/20 0.41
CYP3A4 P08684 1/20 0.41
HTR1A P08908 1/20 0.41
ADRA2A P08913 1/20 0.41
CYP2A6 P11509 1/20 0.41
SLC6A2 P23975 1/20 0.41
HTR2C P28335 1/20 0.41
ADRA1A P35348 1/20 0.41
DRD3 P35462 1/20 0.41
SLC6A3 Q01959 1/20 0.41
KCNH2 Q12809 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Diphenylamine SCHEMBL29173770 0.88 HSD17B10 (0.46) CYP2C19CYP1A2CYP2D6CYP2C9LMNA
SCHEMBL2763439 0.87 CYP2C9 (0.41) CYP2C9LMNAHSD17B10EPHX2
SCHEMBL8313378 0.87 MAOB (0.46) MAOBMAOAKDM1ACYP2C19CYP2B6
SCHEMBL27602398 0.87 KDM1A (0.48) MAOBKDM1ATAAR1CYP3A4HSD17B10
SCHEMBL28262279 0.82 MAOA (0.41) MAOBMAOAKDM1AHTR2CKDM1B
Acetanilide SCHEMBL29173799 0.78 HSD17B10 (0.58) KDM1ATAAR1HSD17B10EPHX2
SCHEMBL18007729 0.78 MAOB (0.35) MAOBMAOAKDM1ACYP2C19CYP2B6
SCHEMBL28331226 0.77 EPHX2 (0.42) HSD11B1EPHX2
SCHEMBL25181452 0.76 KDM1A (0.45) MAOBKDM1ACYP2C9TAAR1CYP2A6
SCHEMBL14299432 0.76 KDM1A (0.45) KDM1ACYP2C9SLC6A2HTR2CSLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117736100-A Preparation method of diphenylamine adamantane substituent compound 维思普新材料(苏州)有限公司 2024-03-22 CN claimed
CN-112341933-B Wear-resistant coating and preparation method thereof 青岛豪纳化工科技有限公司 2022-04-05 CN claimed
CN-113122054-A Preparation method of ink and quantum dot film TCL集团股份有限公司 2021-07-16 CN claimed
CN-112341933-A Wear-resistant coating and preparation method thereof 张瑞平 2021-02-09 CN claimed
CN-120192275-A Cyclobutadiene-containing luminescent material, preparation method and application 深圳大学 2025-06-24 CN disclosed
US-12082487-B2 Organometallic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2024-09-03 US disclosed
EP-3909965-B1 ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO LTD (KR) 2024-08-21 EP disclosed
CN-117736100-A Preparation method of diphenylamine adamantane substituent compound 维思普新材料(苏州)有限公司 2024-03-22 CN disclosed
CN-112341933-B Wear-resistant coating and preparation method thereof 青岛豪纳化工科技有限公司 2022-04-05 CN disclosed
CN-112341933-B Wear-resistant coating and preparation method thereof 青岛豪纳化工科技有限公司 2022-04-05 CN disclosed
CN-113122054-A Preparation method of ink and quantum dot film TCL集团股份有限公司 2021-07-16 CN disclosed
CN-112341933-A Wear-resistant coating and preparation method thereof 张瑞平 2021-02-09 CN disclosed
CN-107434779-A Notch signal pathway inhibitors and its purposes in treatment of cancer 洛桑联邦理工学院(EPFL) 2017-12-05 CN disclosed
CN-104136027-B Notch signaling pathway inhibitors and their use in cancer treatment 洛桑联邦理工学院(EPFL) 2017-05-24 CN disclosed
CN-101031606-B Resin composition, polyimide resin composition, polybenzoxazole resin composition, varnish, resin film and semiconductor device using the same SUMITOMO BAKELITE CO 2011-03-02 CN disclosed
CN-101932618-A Polymer for forming insulating film, composition for forming insulating film, insulating film, and electronic device having insulating film SUMITOMO BAKELITE CO 2010-12-29 CN disclosed
US-20100113816-A1 METHOD FOR PREPARTION OF SUBSTITUTED ADAMANTYLARYMAGNESIUM HALIDES JSC GRINDEKS (LV) 2010-05-06 US disclosed
EP-2129679-A2 A METHOD FOR PREPARATION OF SUBSTITUTED ADAMANTYLARYLMAGNESIUM HALIDES Grindeks, a joint stock company (LV) 2009-12-09 EP disclosed
WO-2008080993-A2 A METHOD FOR PREPARATION OF SUBSTITUTED ADAMANTYLARYLMAGNESIUM HALIDES KALVINSH IVARS (LV) 2008-07-10 WO disclosed
CN-101031606-A Resin composition, polyimide resin composition, polybenzoxazole resin composition, varnish, resin film and semiconductor device using the same SUMITOMO BAKELITE CO (JP) 2007-09-05 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100113816-A1 METHOD FOR PREPARTION OF SUBSTITUTED ADAMANTYLARYMAGNESIUM HALIDES AGL, MACROD1, MACROD2 MAOB 1772/4885MAOA 1644/4885KDM1A 2568/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.